Cassava Sciences, Inc. FLNA
0.75
(0.02)
(2.60%)
as of 25 Sep
- Market cap
- $37.8M
- P/E
- 0.0×
Follow FLNA
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(85.44%) | (82.66%) | (79.59%) | (55.78%) | |
| (59.99%) | (65.95%) | (62.50%) | (35.34%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(129.80%) | (122.08%) | (114.14%) | (66.33%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(1.74) | (0.68) | (0.62) | (0.61) | |
Free Cash Flow |
(83.95) | (32.91) | (29.79) | (29.36) | |
Capital Expenditures |
(0.18) | (0.65) | — | (0.66) | |
| Other line items | |||||
Cash ROIC |
(44.64%) | (18.98%) | (19.26%) | (19.62%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.79 | 0.35 | 0.38 | 0.68 | |
Depreciation/Fixed assets |
0.04 | 0.05 | 0.05 | 0.05 | |
Capex/Depreciation |
(0.22) | (0.70) | 0.00 | (0.67) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.73) | (0.67) | (0.62) | (0.59) | |
Capex per Share |
0.00 | (0.01) | 0.00 | (0.01) | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates